Adcon�Gel registration renewed following KFDA inspection

Following a rigorous inspection by the Korean Food and Drug Administration (KFDA), EMCM – a Leader Biomedical Group company - is proud to announce that our Adcon�Gel registration has been renewed. The registration authorises us to continue distributing the product in Korea for another three years.

“We were impressed by the rigor and professionalism of the KFDA and we are proud to have met their high standards,” said Michael Engelbrecht Director Quality Operations EMCM. “They’ve made helpful recommendations to even further improve the quality of our processes and we are eager to implement their suggestions.”

Produced at EMCM - a centre of excellence for the (contract) manufacturing of Liquids, Suspensions and Gels - Adcon�Gel is a biocompatible, resorbable gel that provides a physical barrier to prevent inter-tissue adhesion.